Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).

Florian Weissinger,Marc Reymond,Klaus Dumke,Martin Krüger

Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).

2011

Florian Weissinger
Marc Reymond
Klaus Dumke
Martin Krüger

Background: For patients with HER2overexpressing gastric cancer, there is an improved prognosis with additional trastuzumab to chemotherapy with a platinum compound and a fluoropyri

Keywords:

FOLFIRI
Cancer
Fluorouracil
Trastuzumab
Oncology
Platinum Compound
Irinotecan
Combination therapy
Chemotherapy
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations